DFX Intelligence
Venture Capital Intelligence
Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.
The names on this page are hidden. Create a free account and they fill in. No card, and every figure, date and source on this page is public either way.
Companies / C•••••• B•• I•••
C•••••• B•• I•••
Unleash the future of multiplex biomarker measurements with the C•••••• Bio Platform. Experience the precision of Digital PCR, and the Dynamic Range of qPCR applied to measurement of blood-based protein biomarkers and nucleic acids.
Facts
Financing history
1 rounds
- May 21, 2024Form D equity offering · $2.3M (form d sold) · 4 investorsFact SEC EDGAR Form D data sets (quarterly) · “C•••••• B•• I••• filed Form D: $2,262,162 sold of $15,816,162, Biotechnology”
Investors on record
1 edges
- G•••• V•••••••• L•• portfolio listing Fact genoavc.com
People
2 officers, 2 directors
- J•••••• C•••••••• Executive Officer/Director sec.gov
- W•••••• H•••••• H••••• Executive Officer sec.gov
- J••• M•••••• H• Director Fact
- J• M•••••• R••••• Director Fact
Timeline
2
- Oct 30, 2024C•••••• B•• I••• filed Form D/A: $12,280,996 sold of $26,437,838, BiotechnologyForm D filed Fact SEC EDGAR Form D data sets (quarterly)
- Jun 5, 2024C•••••• B•• I••• filed Form D: $2,262,162 sold of $15,816,162, BiotechnologyForm D filed Fact SEC EDGAR Form D data sets (quarterly)
Evidence
35 observations
Every observation on this company
- Description: Unleash the future of multiplex biomarker measurements with the C•••••• Bio Platform. Experience the precision of Digital PCR, and the Dynamic Range of qPCR applied to measurement of blood-based protein biomarkers and nucleic acids. Sep 17, 2026 Fact Portfolio company websites (about, investors, press pages)
- Entity type: Corporation Oct 30, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Entity type: Corporation Jun 5, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Form D industry group: Biotechnology Oct 30, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Form D industry group: Biotechnology Jun 5, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Amendment: true Oct 30, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Amendment: false Jun 5, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Revenue range (Form D): Decline to Disclose Oct 30, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Revenue range (Form D): Decline to Disclose Jun 5, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Incorporated: withinFiveYears Oct 30, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Incorporated: withinFiveYears Jun 5, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Jurisdiction: DELAWARE Oct 30, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Jurisdiction: DELAWARE Jun 5, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Amount sold (Form D): $12.3M Oct 30, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Amount sold (Form D): $2.3M Jun 5, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Offering amount (Form D): $26.4M Oct 30, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Offering amount (Form D): $15.8M Jun 5, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Exemptions: 06b Oct 30, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Exemptions: 06b Jun 5, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- First sale: 2024-05-21 Oct 30, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- First sale: 2024-05-21 Jun 5, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Investors (Form D): 4 Oct 30, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Investors (Form D): 4 Jun 5, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Minimum investment (Form D): 0 Oct 30, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Minimum investment (Form D): 0 Jun 5, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Securities offered: equity Oct 30, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Securities offered: equity Jun 5, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Office address: 140 SOUTHCENTER CT., SUITE 200, MORRISVILLE, NC, 27560 Oct 30, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Office address: 140 SOUTHCENTER CT., SUITE 200, MORRISVILLE, NC, 27560 Jun 5, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Listed on portfolio page: G•••• V•••••••• L•• Sep 16, 2026 Fact Venture organization websites (about, team, portfolio, thesis, news pages)
- Listed on portfolio page: G•••• V•••••••• L•• Sep 14, 2026 Fact Venture organization websites (about, team, portfolio, thesis, news pages)
- Website status: ok Sep 17, 2026 Fact Portfolio company websites (about, investors, press pages)
- Site title: C•••••• Bio – Multi-Omics for Precision Medicine Sep 17, 2026 Fact Portfolio company websites (about, investors, press pages)
- Year of incorporation: 2021 Oct 30, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Year of incorporation: 2021 Jun 5, 2024 Fact SEC EDGAR Form D data sets (quarterly)